Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - ASSEMBLY BIOSCIENCES, INC.v472206_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - ASSEMBLY BIOSCIENCES, INC.v472206_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - ASSEMBLY BIOSCIENCES, INC.v472206_ex31-1.htm
EX-10.3 - EXHIBIT 10.3 - ASSEMBLY BIOSCIENCES, INC.v472206_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - ASSEMBLY BIOSCIENCES, INC.v472206_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - ASSEMBLY BIOSCIENCES, INC.v472206_ex10-1.htm
10-Q - FORM 10-Q - ASSEMBLY BIOSCIENCES, INC.v472206_10q.htm

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Assembly Biosciences, Inc. (the Company) for the period ended June 30, 2017 as filed with the Securities and Exchange Commission on or about the date hereof (the Report), I, David J. Barrett, Chief Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Report.

  

  /s/ David J. Barrett
  David J. Barrett
  Chief Financial Officer and Chief Operating Officer
   
  Date: August 9, 2017